Effect of tea beverages on aldehyde oxidase activity

Drug Metabolism and Pharmacokinetics

Volumn 26, Issue 1, 2011, Pages 94-101

  Tayama, Yoshitaka ^a   Sugihara, Kazumi ^a,b   Sanoh, Seigo ^b   Miyake, Katsushi ^a   Morita, Shushi ^a   Kitamura, Shigeyuki ^b,c   Ohta, Shigeru ^b  

^a HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c NIHON PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Aldehyde oxidase; Catechin; Drug drug interaction; Tea beverage

Indexed keywords

1 METHYL 6 OXONICOTINAMIDE; 1 METHYLNICOTINAMIDE; ALDEHYDE OXIDASE; AMIDE; ASCORBIC ACID; CAFFEINE; CATECHIN; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALLOCATECHIN GALLATE; MINERAL WATER; N 1 METHYL 4 PYRIDONE 3 CARBOXAMIDE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ANIMAL TISSUE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CLEARANCE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; FOOD DRUG INTERACTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIVER CYTOSOL; LIVER PARENCHYMA; MALE; NONHUMAN; NOTE; OXIDATION; RAT; TEA;

EID: 79952761589     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-10-NT-078     Document Type: Note

References (46)

1. Beedham, C.: Molybdenum hydroxylases as drug metabolizing enzyme. Drug Metab. Rev., 16: 119-156 1985
2. Berger, R., Mezey, E., Clancy, K. P., Harta, G., Wright, R. M., Repine, J. E., Brown, R. H., Brownstein, M. and Patterson, D.: Analysis of aldehyde oxidase and xanthine dehydrogenase/oxidase as possible candidate genes for autosomal recessive familial amyotrophic lateral sclerosis. Somat. Cell Mol. Genet., 21: 121-131 1995.
3. Moriwaki, Y., Yamamoto, T. and Higashino, K.: Distribution and pathophysiologic role of molybdenum-containing enzymes. Histol. Histopathol., 12: 513-524 1997.
4. Wright, R. M., Vaitaitis, G. M., Weigel, L. K., Repine, T. B., McManaman, J. L. and Repine, J. E.: Identification of the candidate ALS2 gene at chromosome 2q33 as a human aldehyde oxidase gene. Redox Rep., 1: 313-321 1995.
5. Krenitsky, T. A., Tuttle, J. V., Cattau, E. L. and Wang, P.: A comparison of the distribution and electron acceptor specificities of xanthine oxidase and aldehyde oxidase. Comp. Biochem. Physiol., B, 49: 687-703 1974.
6. Moriyasu, A., Sugihara, K., Nakatani, K., Ohta, S. and Kitamura, S.: In vivo-in vitro relationship of methotrexate 7-hydroxylation by aldehyde oxidase in four different strain rats. Drug Metab. Pharmacokinet., 21: 485-491 2006.
7. Kitamura, S., Sugihara, K. and Ohta, S.: Drug-metabolizing ability of molybdenum hydroxylases. Drug Metab. Pharmacokinet., 21: 83-98 2006.
8. Sugihara, K., Kitamura, S. and Tatsumi, K.: Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide. Drug Metab. Dispos., 24: 199-202 1996.
9. Huang, D. Y. and Ichikawa, Y.: Two different enzymes are primarily responsible for retinoic acid synthesis in rabbit liver cytosol. Biochem. Biophys. Res. Commun., 205: 1278-1283 1994.
10. McGeer, E. J. and McGeer, P. L. eds.: Molecular Neurobiology of Mammalian Brain. New York, Plenum Publishing Corp., 1978.
11. De Fusco, R., Biscardi, D. and Mazzacca, F. R.: Bacteriological variations in a medio-mineral water bottled in polyethylene terephthalate containers. Ann. Ig., 1: 1255-1267 1989.
12. Alschuler, L.: Green tea: Healing tonic. Am. J. Nat. Med., 5: 28-31 1998.
13. Graham, H. N.: Green tea composition, consumption, and polyphenol chemistry. Prev. Med., 21: 334-350 1992.
14. Benelli, R., Vene, R., Bisacchi, D., Garbisa, S. and Albini, A.: Anti-invasive effects of green tea polyphenol epigallocatechin-3- gallate EGCG, a natural inhibitor of metallo and serine proteases. Biol. Chem., 383: 101-105 2002.
15. Weisburger, J. H. and Chung, F. L.: Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. Food Chem. Toxicol., 40: 1145-1154 2002.
16. Wu, L. Y., Juan, C. C., Hwang, L. S., Hsu, Y. P., Ho, P. H. and Ho, L. T.: Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur. J. Nutr., 43: 116-124 2004.
17. Dulak, J.: Nutraceuticals as anti-angiogenic agents: hopes and reality. J. Physiol. Pharmacol., 56Suppl. 1: 51-67 2005.
18. Fugh-Berman, A. and Ernst, E.: Herb-drug interactions: review and assessment of report reliability. Br. J. Clin. Pharmacol., 52: 587-595 2001.
19. Markowitz, J. S., Donovan, J. L., DeVane, C. L., Taylor, R. M., Ruan, Y., Wang, J. S. and Chavin, K. D.: Effect of St. Johnös wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA, 290: 1500-1504 2003.
20. Huang, S. M., Hall, S. D., Watkins, P., Love, L. A., Serabjit-Singh, C., Betz, J. M., Hoffman, F. A., Honig, P., Coates, P. M., Bull, J., Chen, S. T., Kearns, G. L. and Murray, M. D.: Drug interactions with herbal products and grapefruit juice: a conference report. Clin. Pharmacol. Ther., 75: 1-12 2004.
21. Huynh, H. T. and Teel, R. W.: Effects of plant-derived phenols on rat liver cytochrome P450 2B1 activity. Anticancer Res., 22: 1699-1703 2002.
22. Maliakal, P. P., Coville, P. F. and Wanwimolruk, S.: Tea consumption modulates hepatic drug metabolizing enzymes in Wistar rats. J. Pharm. Pharmacol., 53: 569-577 2001.
23. Bu-Abbas, A., Clifford, M. N., Walker, R. and Ioannides, C.: Selective induction of rat hepatic CYP1 and CYP4 proteins and of peroxisomal proliferation by green tea. Carcinogenesis, 15: 2575-2579 1994.
24. Sohn, O. S., Surace, A., Fiala, E. S., Richie, J. P., Jr., Colosimo, S., Zang, E. and Weisburger, J. H.: Effects of green and black tea on hepatic xenobiotic metabolizing systems in the male F344 rat. Xenobiotica, 24: 119-127 1994.
25. Pullman, M. E. and Colowick, S. P.: Preparation of 2- and 6- pyridones of N1-methylnicotinamide. J. Biol. Chem., 206: 121-127 1954.
26. Shibata, K., Kawada, T. and Iwai, K.: Simultaneous micro-determination of nicotinamide and its major metabolites, N1- methyl-2-pyridone-5-carboxamide and N1-methyl-4-pyridone-3- carboxamide, by high-performance liquid chromatography. J. Chromatogr., 424: 23-28 1988.
27. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265-275 1951.
28. Tayama, Y., Moriyasu, A., Sugihara, K., Ohta, S. and Kitamura, S.: Developmental changes of aldehyde oxidase in postnatal rat liver. Drug Metab. Pharmacokinet., 22: 119-124 2007.
29. Beedham, C.: Molybdenum hydroxylases: Biological distribution and substrate-inhibitor specificity. Prog. Med. Chem., 24: 85-127 1987.
30. Wright, R. M., Clayton, D. A., Riley, M. G., McManaman, J. L. and Repine, J. E.: CDNA cloning, sequencing, and characterization of male and female rat liver aldehyde oxidase rAOX1. J. Biol. Chem., 274: 3878-3886 1999.
31. Calzi, M. L., Raviolo, C., Ghibaudi, E., de Gioia, L., Salmona, M., Cazzaniga, G., Kurosaki, M., Terao, M. and Garattini, E.: Purification, cDNA cloning, and tissue distribution of bovine liver aldehyde oxidase. J. Biol. Chem., 270: 31037-31045 1995.
32. Terao, M., Kurosaki, M., Saltini, G., Demontis, S., Marini, M., Salmona, M. and Garattini, E.: Cloning of the cDNAs coding for two novel molybdo-flavoproteins showing high similarity with aldehyde oxidase and xanthine oxidoreductase. J. Biol. Chem., 275: 30690-30700 2000.
33. Welshons, W. V., Nagel, S. C. and vom Saal, F. S.: Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology, 147Suppl.: S56-S69 2006.
34. Obach, R. S.: Potent inhibition of human liver aldehyde oxidase by raloxifene. Drug Metab. Dispos., 32: 89-97 2004.
35. Obach, R. S., Huynh, P., Allen, M. C. and Beedham, C.: Human liver aldehyde oxidase: inhibition by 239 drugs. J. Clin. Pharmacol., 44: 7-19 2004.
36. Slain, D., Amsden, J. R., Khakoo, R. A., Fisher, M. A., Lalka, D. and Hobbs, G. R.: Effect of high dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers. Pharmacotherapy, 25: 165-170 2005.
37. Lu, H., Meng, X., Li, C., Sang, S., Patten, C., Sheng, S., Hong, J., Bai, N., Winnik, B., Ho, C. T. and Yang, C. S.: Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug Metab. Dispos., 31: 452-461 2003.
38. Nakamura, T., Asada, E., Nagata, Y. and Kanazawa, H.: Effect of metabolic inhibition against CYP3A4 by catechins in bottled green tea drinks. Bunseki Kagaku, 52: 769-773 2003.
39. Nagao, A., Seki, M. and Kobayashi, H.: Inhibition of xanthine oxidase by flavonoids. Biosci. Biotechnol. Biochem., 63: 1787-1790 1999.
40. Ueda, O., Sugihara, K., Ohta, S. and Kitamura, S.: Involvement of molybdenum hydroxylases in reductive metabolism of nitro polycyclic aromatic hydrocarbons in mammalian skin. Drug Metab. Dispos., 33: 1312-1318 2005.
41. Rajagopalan, K. V. and Handler, P.: Hepatic aldehyde oxidase II. Differential inhibition of electron transfer to various electron acceptors. J. Biol. Chem., 239: 2022-2026 1964.
42. Rajagopalan, K. V. and Handler, P.: Hepatic aldehyde oxidase. III. The substrate-binding site. J. Biol. Chem., 239: 2027-2035 1964.
43. Sugihara, K., Kitamura, S. and Tatsumi, K.: Involvement of mammalian liver cytosols and aldehyde oxidase in reductive metabolism of zonisamide. Drug Metab. Dispos., 24: 199-202 1996.
44. Schofield, P. C., Robertson, I. G. C. and Paxton, J. W.: Inter- species variation in the metabolism and inhibition of N-2'- dimethylaminoethyl«acridine-4-carboxamide DACA by aldehyde oxidase. Biochem. Pharmacol., 59: 161-165 2000.
45. Donovan, J. L., Chavin, K. D., Devane, C. L., Taylor, R. M., Wang, J. S., Ruan, Y. and Markowitz, J. S.: Green tea Camellia sinensis extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers. Drug Metab. Dispos., 32: 906-908 2004.
46. Chow, H. H., Hakim, I. A., Vining, D. R., Crowell, J. A., Ranger-Moore, J., Chew, W. M., Celaya, C. A., Rodney, S. R., Hara, Y. and Alberts, D. S.: Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin. Cancer Res., 11: 4627-4633 2005.